Gvoke HypoPen 1 mg in 0.2 mL Auto-Injector
RxNorm 2199308
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2199308 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Gvoke HypoPen 1 mg in 0.2 mL Auto-Injector.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
0.2 mL glucagon 5 mg/ML Auto-Injector [Gvoke]
(Atom ID: 12358245)
SYPrescribable
Synonym (SY):
0.2 mL Gvoke 5 mg/ML Auto-Injector
(Atom ID: 11447320)
PSNPrescribable
Prescribable Name (PSN):
Gvoke HypoPen 1 mg in 0.2 mL Auto-Injector
(Atom ID: 11447319)
SYPrescribable
Synonym (SY):
Gvoke HypoPen 1 mg per 0.2 mL Auto-Injector
(Atom ID: 11447321)
Patient Education
Glucagon Injection
Glucagon is used along with emergency medical treatment to treat very low blood sugar. Glucagon is also used in diagnostic testing of the stomach and other digestive organs. Glucagon is in a class of medications called glycogenolytic agents. It works by causing the liver to release stored sugar to the blood. It also works by relaxing smooth muscles of the stomach and other digestive organs for diagnostic testing.
[Learn More]
* Please review the disclaimer below.